Literature DB >> 34942122

Movement disorders research in 2021: cracking the paradigm.

Alberto J Espay1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34942122     DOI： 10.1016/S1474-4422(21)00413-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

Review 1.  Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice.

Authors:  Lars Tönges; Carsten Buhmann; Stephan Klebe; Jochen Klucken; Eun Hae Kwon; Thomas Müller; David J Pedrosa; Nils Schröter; Peter Riederer; Paul Lingor
Journal:  J Neural Transm (Vienna)       Date:  2022-04-15       Impact factor: 3.850

2.  Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease.

Authors:  Hiroaki Sekiya; Asato Tsuji; Yuki Hashimoto; Mariko Takata; Shunsuke Koga; Katsuya Nishida; Naonobu Futamura; Michi Kawamoto; Nobuo Kohara; Dennis W Dickson; Hisatomo Kowa; Tatsushi Toda
Journal:  Acta Neuropathol Commun       Date:  2022-09-06       Impact factor: 7.578

3.  Neurons with Cat's Eyes: A Synthetic Strain of α-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions.

Authors:  Francesca De Giorgi; Muhammed Bilal Abdul-Shukkoor; Marianna Kashyrina; Leslie-Ann Largitte; Francesco De Nuccio; Brice Kauffmann; Alons Lends; Florent Laferrière; Sébastien Bonhommeau; Dario Domenico Lofrumento; Luc Bousset; Erwan Bezard; Thierry Buffeteau; Antoine Loquet; François Ichas
Journal:  Biomolecules       Date:  2022-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.